Latest News about BIIB
Recent news which mentions BIIB
   7 Undervalued S&P 500 Stocks to Buy in June
   
  
  
  June 15, 2023
  From InvestorPlace
 
   Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed
   
  
  
  June 14, 2023
  From Benzinga
 
   Methode Electronics, Brookfield Renewable Partners And Other Big Stocks Moving Lower On Tuesday
   
  
  
  June 13, 2023
  From Benzinga
 From Benzinga
 
   Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
   
  
  
  June 13, 2023
  From Benzinga
 
   Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
   
  
  
  June 12, 2023
  From Benzinga
 
   Why Are Cruise Stocks CCL, RCL, NCLH Up Today?
   
  
  
  June 12, 2023
  From InvestorPlace
 From InvestorPlace
 From Benzinga
 
   Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target
   
  
  
  June 12, 2023
  From MarketWatch
 
   Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move
   
  
  
  June 12, 2023
  From MarketWatch
 From MarketWatch
 
   Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
   
  
  
  June 08, 2023
  From Benzinga
 
   FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
   
  
  
  June 08, 2023
  From Benzinga
 
   Thinking Of Buying Boston Properties? Here Are The Properties And Tenants You'd Add To Your Portfolio
   
  
  
  June 07, 2023
  From Benzinga
 
   Biogen and Denali Realign Parkinson's Disease Research Priorities Amidst R&D Restructure
   
  
  
  June 05, 2023
  From Benzinga
 From MarketWatch
 From MarketWatch
 
   New Alzheimer’s drug could bring hope to patients, but could be out of reach for people on Medicare
   
  May 25, 2023
  Tickers 
   BIIB
  
  
  From MarketWatch
 From InvestorPlace
 
   1 Major Advantage Biogen May Have Over Pharma Giant Eli Lilly in a Multibillion-Dollar Market
   
  
  
  May 19, 2023
  From Motley Fool
 From Motley Fool
 From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.